Shinyoung Securities logo

Shinyoung Securities

Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo

Description

Shinyoung Securities is a financial service provider company.

Investor Profile

Shinyoung Securities has made 4 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series C (25%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Software
  • Content
  • Digital Media
  • Media And Entertainment
  • Biotechnology
  • Medical
  • Human Computer Interaction
  • Product Design
  • Saas
  • Ux Design
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shinyoung Securities frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
HB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Korea Technology Finance Corporation
Asia, Pusan-jikhalsi, South Korea, Busan
Co-Investments: 1
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
STIC Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Crux Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Gaia Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Atinum Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Bokwang Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Shinyoung Securities?

ProtoPie

Seoul, Seoul-t'ukpyolsi, South Korea

The easiest interaction design tool for all digital products, allowing designers to build highly interactive prototypes.

Human Computer InteractionProduct DesignSaaSSoftwareUX Design
Series BJan 22, 2025
Amount Raised: $21,000,000
Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
AITRICS

Seocho, Seoul-t'ukpyolsi, South Korea

AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence.

AnalyticsArtificial Intelligence (AI)Health CareInformation TechnologySoftware
Series BMar 21, 2024
Amount Raised: $20,299,925
Sangwha

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Sangwha is an immersive content production company.

ContentDigital MediaMedia and Entertainment
Series UnknownJul 31, 2023
Amount Raised: $11,734,555